These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 565732)

  • 21. [Clinical use of combined contraceptive preparations of Hungarian manufacture].
    Farkas M
    Akush Ginekol (Mosk); 1983 Nov; (11):11-4. PubMed ID: 6364870
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Studies in mice on the mutagenicity of two contraceptive drugs.
    Wallace ME; Badr FM; Badr RS
    J Med Genet; 1979 Jun; 16(3):206-9. PubMed ID: 469899
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Three and one-half years' experience with a lower-dose combination oral contraceptive.
    Woutersz TB
    J Reprod Med; 1976 Jun; 16(6):338-44. PubMed ID: 957360
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Contraception with levonorgestrel, 0.15 mg, and ethinyl estradiol, 0.03 mg. Clinical studies in Latin America.
    Moggia AV
    J Reprod Med; 1983 Jan; 28(1 Suppl):77-80. PubMed ID: 6403704
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical experience with a low-dose contraceptive agent. European studies.
    Haspels AA
    J Reprod Med; 1983 Jan; 28(1 Suppl):71-6. PubMed ID: 6403703
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Co-occurring liver cell adenoma and focal nodular hyperplasia due to contraceptives. Case report].
    Reichlin B; Stalder GA; Rüedi T; Bianchi L
    Schweiz Med Wochenschr; 1980 May; 110(22):873-4. PubMed ID: 6250211
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [3- month therapy cycles for oral contraception?].
    Lauritzen C
    Dtsch Med Wochenschr; 1977 Dec; 102(51):1891. PubMed ID: 598292
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Urinary estrogen and serum gonadotropin profiles in women ingesting oral contraceptive steroid formulations with variable estrogen content.
    Grimes EM; Thompson IE; Taymor ME
    J Natl Med Assoc; 1983 Jun; 75(6):575-80. PubMed ID: 6410078
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The critical oestrogen content of combined oral contraceptives.
    Mumford JP
    J Int Med Res; 1975; 3(6):407-12. PubMed ID: 1228040
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The efficacy of gestoden (delta 15-d-norgestrel) as ovulation inhibitor (author's transl)].
    Schneider WH; Schmid R; Spona J
    Wien Klin Wochenschr; 1981 Oct; 93(19):601-4. PubMed ID: 6798765
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The 150/30 formulation. Experience in the United Kingdom.
    Guillebaud J
    J Reprod Med; 1983 Jan; 28(1 Suppl):66-70. PubMed ID: 6403702
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Laboratory and clinical study with a new progestagen combined with ethinyl estradiol used in contraception].
    Galán G; Gayán P; Tisné L
    Rev Chil Obstet Ginecol; 1985; 50(4):317-24. PubMed ID: 2953049
    [No Abstract]   [Full Text] [Related]  

  • 33. Liver function tests in patients on oral progestogens.
    Engineer AD; Gupta V; Tandon P
    J Obstet Gynaecol India; 1968 Apr; 18(2):598-605. PubMed ID: 12331828
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinical trial of a combined oral contraceptive with low estrogen dose (author's transl)].
    Schmidt-Elmendorff HW
    MMW Munch Med Wochenschr; 1975 Feb; 117(9):345-8. PubMed ID: 804642
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk of nonfatal venous thromboembolism in women using a contraceptive transdermal patch and oral contraceptives containing norgestimate and 35 microg of ethinyl estradiol.
    Brenner P
    Contraception; 2006 Oct; 74(4):354; author reply 354-5. PubMed ID: 16982246
    [No Abstract]   [Full Text] [Related]  

  • 36. Evaluation of the contraceptive efficacy, compliance, and satisfaction with the transdermal contraceptive patch system Evra: a comparison between adolescent and adult users.
    Bodner K; Bodner-Adler B; Grünberger W
    Arch Gynecol Obstet; 2011 Mar; 283(3):525-30. PubMed ID: 20111970
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oral contraception reviewed.
    Elstein M
    IPPF Med Bull; 1979 Jun; 13(3):1-2. PubMed ID: 12335871
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Oral contraceptives: 30 vs 20 micrograms of ethinyl estradiol (EE)].
    Urdinola J
    Adv Contracept; 1994 Jul; 10 Suppl 1():41-9. PubMed ID: 7839871
    [No Abstract]   [Full Text] [Related]  

  • 39. Blood coagulation with a combination pill containing gestodene and ethinyl estradiol.
    Bonnar J; Daly L; Carroll E
    Int J Fertil; 1987; 32 Suppl():21-8. PubMed ID: 2906344
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Experience in the 2-phase use of estrogens and gestagens for contraception].
    Ivanov AA; Primak AN
    Vopr Okhr Materin Det; 1970 Dec; 15(12):36-40. PubMed ID: 4101955
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.